ConductScience.org, home

Paper39477378

Molecular Hydrogen Therapy in Sjögren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell.

Lin YT and 6 others. In Vivo, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Molecular Hydrogen Therapy in Sjögren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell. Papers, record 39477378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39477378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Hydrogen Therapy in Sjögren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell.
PubMed
Journal
In Vivo
PubMed
Year
2024
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.09, provisional
iCite
Revised in PubMed
2025-01-31
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin YTYun-Ting
2Lu JWJeng-Wei
3Wu CHChun-Hsien
4Ho YJYi-Jung
5Lui SWShan-Wen
6Hsieh TYTing-Yu
7Liu FCFeng-Cheng

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sjogren's SyndromeMajor topic
Heart FailureMajor topic
HydrogenMajor topic
Pulmonary Arterial HypertensionMajor topic
T-Lymphocytes, RegulatoryMajor topic
Humans
Female
Middle Aged
B-Lymphocytes
Biomarkers
Treatment Outcome

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138688598Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.In Vivo2024https://conductscience.org/library/papers/38688598PubMed
238107500Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial.Ther Clin Risk Manag2023https://conductscience.org/library/papers/38107500PubMed
335187885Molecular hydrogen is a promising therapeutic agent for pulmonary disease.J Zhejiang Univ Sci B2022https://conductscience.org/library/papers/35187885PubMed
438795643Potential role of molecular hydrogen therapy on oxidative stress and redox signaling in chronic kidney disease.Biomed Pharmacother2024https://conductscience.org/library/papers/38795643PubMed
536624795Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia.JACC Asia2022https://conductscience.org/library/papers/36624795PubMed
635883781Coral Hydrate, a Novel Antioxidant, Improves Alcohol Intoxication in Mice.Antioxidants (Basel)2022https://conductscience.org/library/papers/35883781PubMed
734100160Sjögren's syndrome: a systemic autoimmune disease.Clin Exp Med2022https://conductscience.org/library/papers/34100160PubMed
838067515Molecular Hydrogen Therapy-A Review on Clinical Studies and Outcomes.Molecules2023https://conductscience.org/library/papers/38067515PubMed
933095142Interstitial lung disease in Sjögren's syndrome: a clinical review.Clin Exp Rheumatol2020https://conductscience.org/library/papers/33095142PubMed
1021687512Hydrogen Therapy may be a Novel and Effective Treatment for COPD.Front Pharmacol2011https://conductscience.org/library/papers/21687512PubMed
1123829793Pulmonary arterial hypertension.Orphanet J Rare Dis2013https://conductscience.org/library/papers/23829793PubMed
1235250621Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.Front Physiol2022https://conductscience.org/library/papers/35250621PubMed
1338929185A Novel Antioxidant, Hydrogen-Rich Coral Calcium Alters Gut Microbiome and Bile Acid Synthesis to Improve Methionine-and-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease.Antioxidants (Basel)2024https://conductscience.org/library/papers/38929185PubMed
1438088955Connective tissue disease-associated pulmonary hypertension: A comprehensive review.Pulm Circ2023https://conductscience.org/library/papers/38088955PubMed
1528610655The Diagnosis and Treatment of Sjögren's Syndrome.Dtsch Arztebl Int2017https://conductscience.org/library/papers/28610655PubMed
1637652509Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis.In Vivo2023https://conductscience.org/library/papers/37652509PubMed
1724355643Updated treatment algorithm of pulmonary arterial hypertension.J Am Coll Cardiol2013https://conductscience.org/library/papers/24355643PubMed
1826320113
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Eur Heart J2016https://conductscience.org/library/papers/26320113PubMed
1917376507Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases.Hum Pathol2007https://conductscience.org/library/papers/17376507PubMed
2037439387Predicting the clinical efficacy of JAK inhibitor treatment for patients with rheumatoid arthritis based on Fas+ T cell subsets.APMIS2023https://conductscience.org/library/papers/37439387PubMed

See all 29 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42957267Sustained Tocilizumab and Adjunctive HydroBox Therapy in Refractory Takayasu Arteritis: An 11-year Case Report.In Vivo2026https://conductscience.org/library/papers/42957267PubMed
42668873Research Progress of Molecular H2 in Mediating Immune Tolerance via Regulating Tregs-from the Perspective of the 2025 Nobel Prize in Physiology or Medicine.Drug Des Devel Ther2026https://conductscience.org/library/papers/42668873PubMed
42379742Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping.In Vivo2026https://conductscience.org/library/papers/42379742PubMed
42255997Molecular hydrogen is associated with immunophenotypic modulation and changes in T-cell exhaustion markers in refractory primary Sjögren's syndrome-associated interstitial lung disease: A case report.SAGE Open Med Case Rep2026https://conductscience.org/library/papers/42255997PubMed
42164762A narrative review of hydrogen therapy for COPD: aging-related insights.Open Med (Wars)2026https://conductscience.org/library/papers/42164762PubMed
41760342Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.In Vivo2026https://conductscience.org/library/papers/41760342PubMed
41482418Longitudinal Immune Profiling of T Cell Exhaustion During IL-17A Blockade in a Patient With HLA-B27-negative Spondyloarthritis and Sjögren's Syndrome: A Case Report.In Vivo2026https://conductscience.org/library/papers/41482418PubMed
41482388Adjuvant Molecular Hydrogen Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report on Immunomodulatory Effects on Regulatory and Effector Lymphocytes.In Vivo2026https://conductscience.org/library/papers/41482388PubMed
41254431H2 as a potential redox homeostasis modulator: a review of mechanisms targeting key elements of cardiovascular pathogenesis-related pathways.Mol Cell Biochem2026https://conductscience.org/library/papers/41254431PubMed
40877145Immunomodulatory Effects of Molecular Hydrogen Therapy in Systemic Lupus Erythematosus With Pericarditis and Pleuritis: A Case Report.In Vivo2025https://conductscience.org/library/papers/40877145PubMed
40579028Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation.In Vivo2025https://conductscience.org/library/papers/40579028PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL7R3575PubTator's text mininghttps://conductscience.org/library/genes/3575

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39477378

GET https://conductscience.org/api/papers/v1/39477378/references?page=2